Advertisement for orthosearch.org.uk
Results 1 - 3 of 3
Results per page:
Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXV | Pages 216 - 216
1 Jun 2012
Shnayien S
Full Access

Background and Objective. In industrialized societies, the prevalence of radicular low back pain has exploded in recent years. Lumbar disc prolaps, protrusion, or extrusion account for less than 5% of all low back problems, but are the most common causes of nerve root pain and surgical interventions. The primary rationale for any form of surgery for disc prolaps is to relieve nerve root irritation or compression due to herniated disc material. The primary modality of surgical treatment continues to be either open or microdiscectomy, but several alternative techniques including. Nucleoplasty. It provokes ablation of the nucleus of the disk by a controlled thermal effect produced by radiofrequency. Nucleoplasty is minimally invasive treatment aimed at removing nuclear material and lowering intradiscal pressure and decompressing through coblation needle inserted percutaneously into the nucleus of intervertebral discs. This paper will show a 3 years experience with 110 cases with lumbar radicular pain secondary to a disc protrusion that underwent Nucleoplasty as their secondary therapy. Methods. Included in this series were 110 patients with significant lumbar radicular pain, resistant to interventional therapy done before hand like fluoroscopically guided spinal transforaminal epidural injections or sacral injections with steroids. These cases were done under local anaesthesia with short analgesia and stand by monitoring. Results. In the overall cohort, the average Visual Analogue Scale (VAS) pain score decreased. Conclusions. We conclude that with use of the present selection criteria, Nucleoplasty is very effective long-term treatment for lumbar radicular pain. We recommend modifying the criteria to include only those cases with lumbar radicular pain due to protrusion whose annular integrity is confirmed via MRI and by either selective nerve root blocks and to exclude cases with axial pain


Orthopaedic Proceedings
Vol. 95-B, Issue SUPP_1 | Pages 181 - 181
1 Jan 2013
Khan Y Jones A Mushtaq S Murali K
Full Access

Introduction and aims. Low back pain is a common complaint, affecting up to one third of the adult population costing over £1 billion to the NHS each year and £3.5 billion to the UK economy in lost production. The demand for spinal injections is increasing allowing for advanced spinal physiotherapists to perform the procedure. The objective of this study was to investigate outcome following spinal injections performed by consultant spinal surgeon (n=40) and advanced spinal physiotherapists (ASP) (n=40) at our centre. Method and Materials. Data on 80 patients who had received caudal epidural (n=36), nerve root block (n=28) and facet joint injections (n=16) form August 2010 to October 2011 consented to be in the study. 40 patients in each group completed Oswestry Disability Index (ODI), Visual Analogue Scores (VAS) before and 6 weeks after the procedure and patient satisfaction questionnaire investigating their experience and any complications related to the spinal injection retrospectively. The study included 32 males and 48 females. Mean age 57 years, range 21–88. [Consultant group M:17, F:23 mean age: 55, range 21–81. ASP group M:15, F:25 mean age 59, range 22–88]. Measures of patient satisfaction and outcome were obtained; using 2 tailed independent samples t-test with 95% confidence interval, statistical significance was investigated. Results. Data analysis shows that there are no significant differences (p>0.05) in either overall patient satisfaction or outcomes between patients of the surgeon vs physiotherapists. Patients of the surgeon were found to be more satisfied with the procedure itself (p< 0.05). Conclusion. Physiotherapists are able to provide spinal injections with equal efficacy to spinal surgeons, with no reduction in overall patient outcome. Benefits of this scheme include greater number of spinal injections performed. Therefore, reducing the overall waiting times. Further, multi-centre studies on larger populations are required to investigate injection treatment by physiotherapists


Bone & Joint Open
Vol. 1, Issue 8 | Pages 450 - 456
1 Aug 2020
Zahra W Dixon JW Mirtorabi N Rolton DJ Tayton ER Hale PC Fisher WJ Barnes RJ Tunstill SA Iyer S Pollard TCB

Aims

To evaluate safety outcomes and patient satisfaction of the re-introduction of elective orthopaedic surgery on ‘green’ (non-COVID-19) sites during the COVID-19 pandemic.

Methods

A strategy consisting of phased relaxation of clinical comorbidity criteria was developed. Patients from the orthopaedic waiting list were selected according to these criteria and observed recommended preoperative isolation protocols. Surgery was performed at green sites (two local private hospitals) under the COVID-19 NHS contract. The first 100 consecutive patients that met the Phase 1 criteria and underwent surgery were included. In hospital and postoperative complications with specific enquiry as to development of COVID-19 symptoms or need and outcome for COVID-19 testing at 14 days and six weeks was recorded. Patient satisfaction was surveyed at 14 days postoperatively.